Sonic Healthcare
(ASX:SHL) has raised €160 million of long-term debt funding as part of refunding expiring bank debt facilities.
The notes have been issued in the US private placement market.
Seventy-five million euro of the notes have a 7-year maturity, and €85 million worth of notes will see through 15 years, which lengthens the global healthcare company’s debt maturity profile.
Sonic’s Finance Director and CFO said the transaction received strong support from both existing and new investors, and said this market will continue to be an attractive source of funding for Sonic.
The remainder of Sonic’s expiring bank debt facilities have been refinanced through a new 5 and a half year revolving bank facility.
Shares in Sonic Healthcare
(ASX:SHL) are trading 0.23 per cent higher to $21.93.
